109425-51-6 Fmoc-L-His(Trt)-OH

109425-51-6 Fmoc-L-His(Trt)-OH

Short Description:

Appearance White to off-white powder
MF C40H33N3O4
MW 619.71
Purity 98+

Product Detail

Transportation condition
Could be in normal temperature

Recommend shipping method
By air     By land      By sea

Storage condition:
Keep in dark place,Inert atmosphere,Room temperature

Shelf life
About 2 years

Minimum Order Qty:
1kg (negotiation)

Certification: COA, melting point, SpecificRotation [α]D20                      

We will send any data you want. You can see the data before as reference.

For customized products, we send the newest data after they come out.

D-Lys(tfa)-NCA (2)











inner Packing

They are often used for packing powder. It depends on customers` requirement. Therefore, tell us your demanding before packing if you have special requests.

Inner packing 2
Inner packing 1
Inner packing 3

outer packing

1kg to 25kg The outer packing is hard. And it is difficult to cut and damage. It can protect your products perfectly.

Outer packing 3
Outer packing 2
Outer packing 1


109425-51-6  Fmoc-L-His(Trt)-OH belongs to L-histidine derivatives, which is an essential human amino acid, compared with other amino acids, in addition to some common chemical reactions L-histidine due to its right side chain imidazole group and diazobenzenesulfonic acid can form a brownish-red compound, that is, Pauly (Pauly) reaction.

109425-51-6  Fmoc-L-His(Trt)-OH also can be one of Triptorelin Acetate Intermediates.Triptorelin, a decapeptide (pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2), is a gonadotropin-releasing hormone agonist (GnRH agonist) used as the acetate or pamoate salts. By causing constant stimulation of the pituitary, it decreases pituitary secretion of gonadotropins luteinizing hormone (LH) and follicle stimulating hormone (FSH). Like other GnRH agonists, triptorelin may be used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer, precocious puberty, estrogen-dependent conditions (such as endometriosis or uterine fibroids), and in assisted reproduction. It is also used as therapy in cases of gender dysphoria.

During the treatment of prostate cancer it does cause a surge of testosterone (an initial uplevel of testosterone levels), known as a flare effect. In men a reduction of serum testosterone levels into the range normally seen after surgical castration occurs approximately two to four weeks after initiation of therapy. In contrast, gonadotropin-releasing hormone antagonists do not cause a surge, but a sudden reduction of testosterone levels.

related products

L-His-OH D-His-OH L-His(trt)-OH D-His(trt)-OH
Boc-L-His-OH Boc-L-His(trt)-OH Boc-D-His(trt)-OH Fmoc-L-His-OH
Fmoc-D-His(Trt)-OH Boc-His(Trt)-Gly-OH Boc-L-His(Trt)-Aib-OH Fmoc-His(Mmt)-OH

Why Choose Us

1. About the MOQ: We can adjust it according to your requirement.
2. About the sample: The sample requires the sample fee, which can be freight to collect or you can pay to us in advance.
3. Mold workshop, can be customized according to the number of models.
4. We provide the best service. An experienced sales team is already working for you.
5. About the exchange: Please email or chat me at your convenience.

  • Previous:
  • Next:

  • Write your message here and send it to us